State Ledger
Company profile

Acrivon Therapeutics, Inc. CIK 1781174

Ticker
ACRV (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Watertown, MA 02472
Fiscal year end
2025 (FY)
Market Data
Close
$1.91
Change
+$0.04
Change %
2.14%
Volume
11,983

ACRV · trading date Oct 9, 2026 · previous close $1.87 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$77.91M
Total assets
$129.72M
Total liabilities
$17.20M
Stockholders' equity
$112.52M
Cash & equivalents
$41.50M
Operating income
-$84.11M
Operating cash flow
-$63.67M
Capital expenditures
$1.67M

Fiscal year 2025, via 10-K filed 2026-03-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$65.33M
Free cash flow margin
—
Liabilities / assets
13.3%
Equity / assets
86.7%
CapEx / revenue
—
Operating cash flow / net income
0.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$77.91M $129.72M $17.20M $112.52M
2024 — -$80.56M $196.59M $19.80M $176.79M
2023 — -$60.39M $138.27M $17.07M $121.20M
2022 — -$31.17M $181.23M $10.75M $170.48M
2021 — -$16.24M $106.59M $7.88M -$23.81M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-02
Financials filed via
Form 10-K
filed 2026-03-19

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Watertown, MA 02472
480 ARSENAL WAY, SUITE 100
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies